The Repertoire of Mutational Signatures in Human Cancer

Ludmil B. Alexandrov(University of California San Diego), Jaegil Kim(Broad Institute), Nicholas J. Haradhvala(Broad Institute), Mi Ni Huang(Duke-NUS Medical School), Alvin Wei Tian Ng(Duke-NUS Medical School), Yang Wu(Duke-NUS Medical School), Arnoud Boot(Duke-NUS Medical School), Kyle R. Covington(Baylor College of Medicine), Dmitry A. Gordenin(National Institutes of Health), Erik N. Bergstrom(University of California San Diego), S. M. Ashiqul Islam(University of California San Diego), Núria López-Bigas(Institució Catalana de Recerca i Estudis Avançats), Leszek J. Klimczak(National Institutes of Health), John R. McPherson(Duke-NUS Medical School), Sandro Morganella(Wellcome Sanger Institute), Radhakrishnan Sabarinathan(Universitat Pompeu Fabra), David A. Wheeler(Baylor College of Medicine), Ville Mustonen(University of Helsinki), the PCAWG Mutational Signatures Working Group(Broad Institute), Gad Getz(Broad Institute), Steve Rozen(Wellcome Sanger Institute), Michael R. Stratton(Wellcome Sanger Institute)
bioRxiv (Cold Spring Harbor Laboratory)
May 15, 2018
Cited by 548Open Access
Full Text

Abstract

ABSTRACT Somatic mutations in cancer genomes are caused by multiple mutational processes each of which generates a characteristic mutational signature. Using 84,729,690 somatic mutations from 4,645 whole cancer genome and 19,184 exome sequences encompassing most cancer types we characterised 49 single base substitution, 11 doublet base substitution, four clustered base substitution, and 17 small insertion and deletion mutational signatures. The substantial dataset size compared to previous analyses enabled discovery of new signatures, separation of overlapping signatures and decomposition of signatures into components that may represent associated, but distinct, DNA damage, repair and/or replication mechanisms. Estimation of the contribution of each signature to the mutational catalogues of individual cancer genomes revealed associations with exogenous and endogenous exposures and defective DNA maintenance processes. However, many signatures are of unknown cause. This analysis provides a systematic perspective on the repertoire of mutational processes contributing to the development of human cancer including a comprehensive reference set of mutational signatures in human cancer.


Related Papers

No related papers found

Powered by citation graph analysis